These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 1838494)
1. Stereoselective inhibition by D- and L-alanine of phencyclidine-induced locomotor stimulation in the rat. Tanii Y; Nishikawa T; Hashimoto A; Takahashi K Brain Res; 1991 Nov; 563(1-2):281-4. PubMed ID: 1838494 [TBL] [Abstract][Full Text] [Related]
2. Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat. Tanii Y; Nishikawa T; Hashimoto A; Takahashi K J Pharmacol Exp Ther; 1994 Jun; 269(3):1040-8. PubMed ID: 8014848 [TBL] [Abstract][Full Text] [Related]
3. D-alanine inhibits methamphetamine-induced hyperactivity in rats. Hashimoto A; Nishikawa T; Oka T; Takahashi K Eur J Pharmacol; 1991 Sep; 202(1):105-7. PubMed ID: 1664801 [TBL] [Abstract][Full Text] [Related]
4. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline. Witkin JM; Steele TD; Sharpe LG J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180 [TBL] [Abstract][Full Text] [Related]
5. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. Bristow LJ; Hutson PH; Thorn L; Tricklebank MD Br J Pharmacol; 1993 Apr; 108(4):1156-63. PubMed ID: 8485625 [TBL] [Abstract][Full Text] [Related]
6. Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated. Ogren SO; Goldstein M Neuropsychopharmacology; 1994 Nov; 11(3):167-77. PubMed ID: 7865098 [TBL] [Abstract][Full Text] [Related]
7. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat. Klamer D; Zhang J; Engel JA; Svensson L Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002 [TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin B receptor antagonists enhance the locomotor response to the N-methyl-D-aspartate antagonists phencyclidine and dizocilpine maleate. Blacker D; Broberger C; Ogren SO; Hökfelt T Neuroscience; 1997 Feb; 76(4):1057-67. PubMed ID: 9027866 [TBL] [Abstract][Full Text] [Related]
9. D-serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia. Contreras PC Neuropharmacology; 1990 Mar; 29(3):291-3. PubMed ID: 2109276 [TBL] [Abstract][Full Text] [Related]
10. N-methyl-D-aspartate receptors in associative eyeblink conditioning: both MK-801 and phencyclidine produce task- and dose-dependent impairments. Thompson LT; Disterhoft JF J Pharmacol Exp Ther; 1997 May; 281(2):928-40. PubMed ID: 9152403 [TBL] [Abstract][Full Text] [Related]
11. Metaphit, a proposed phencyclidine (PCP) antagonist, prevents PCP-induced locomotor behavior through mechanisms unrelated to specific blockade of PCP receptors. French ED; Jacobson AE; Rice KC Eur J Pharmacol; 1987 Aug; 140(3):267-74. PubMed ID: 2820762 [TBL] [Abstract][Full Text] [Related]
13. The role of NMDA and sigma systems in the behavioral effects of phencyclidine in preweanling rats. Scalzo FM; Burge LJ Neurotoxicology; 1994; 15(1):191-200. PubMed ID: 8090359 [TBL] [Abstract][Full Text] [Related]
14. Spatial and temporal patterning distinguishes the locomotor activating effects of dizocilpine and phencyclidine in rats. Lehmann-Masten VD; Geyer MA Neuropharmacology; 1991 Jun; 30(6):629-36. PubMed ID: 1922682 [TBL] [Abstract][Full Text] [Related]
15. A novel analog of olanzapine linked to sarcosinyl moiety (PGW5) demonstrates high efficacy and good safety profile in mouse models of schizophrenia. Gil-Ad I; Portnoy M; Tarasenko I; Bidder M; Kramer M; Taler M; Weizman A Eur Neuropsychopharmacol; 2014 Mar; 24(3):425-36. PubMed ID: 24389121 [TBL] [Abstract][Full Text] [Related]
16. Antipsychotic-like effects of the N-methyl-D-aspartate receptor modulator neboglamine: an immunohistochemical and behavioural study in the rat. Chiusaroli R; Garofalo P; Espinoza S; Neri E; Caselli G; Lanza M Pharmacol Res; 2010 May; 61(5):430-6. PubMed ID: 20045056 [TBL] [Abstract][Full Text] [Related]
17. Activation-related and activation-independent effects of polyamines on phencyclidine receptor binding within the N-methyl-D-aspartate receptor complex. Javitt DC; Frusciante MJ; Zukin SR J Pharmacol Exp Ther; 1994 Aug; 270(2):604-13. PubMed ID: 7915316 [TBL] [Abstract][Full Text] [Related]
18. Comparative electroencephalographic and behavioral effects of phencyclidine, (+)-SKF-10,047 and MK-801 in rats. Marquis KL; Paquette NC; Gussio RP; Moreton JE J Pharmacol Exp Ther; 1989 Dec; 251(3):1104-12. PubMed ID: 2557412 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat. Umino A; Takahashi K; Nishikawa T Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556 [TBL] [Abstract][Full Text] [Related]
20. Phencyclidine-induced abnormal behaviors in rats as measured by the hole board apparatus. Morita T; Sonoda R; Nakato K; Koshiya K; Wanibuchi F; Yamaguchi T Psychopharmacology (Berl); 2000 Feb; 148(3):281-8. PubMed ID: 10755741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]